Cargando…

Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases

BACKGROUND: Cancer immunotherapy is rapidly expanding but its clinical efficacy is hampered by immune related adverse events (ir-AE). There is a concern regarding patients with pre-existing auto-immune diseases (PAD) undergoing immunotherapy. METHODS: An electronic search was performed (Medline) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klavdianou, Kalliopi, Melissaropoulos, Konstantinos, Filippopoulou, Alexandra, Daoussis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Mediterranean Journal of Rheumatology (MJR) 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693295/ https://www.ncbi.nlm.nih.gov/pubmed/34964025 http://dx.doi.org/10.31138/mjr.32.3.218

Ejemplares similares

Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2020)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment
por: Alexandropoulou, Ioanna, et al.
Publicado: (2023)

Chronic Rheumatism and the Pre-Rheumatic State
Publicado: (1933)

Safe food: should we be afraid?
por: Grierson, W
Publicado: (1999)

Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list
por: Speth, Fabian, et al.
Publicado: (2018)

Trauma in the Aggravation of Pre-Existing Disease
por: M'Bride, J. Graham
Publicado: (1913)

Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
por: Boland, Patrick, et al.
Publicado: (2020)

Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2022)

Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
por: Sharma, Praveen, et al.
Publicado: (2021)

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Pre-Existing Liver Disease and Toxicity of Antifungals
por: Spernovasilis, Nikolaos, et al.
Publicado: (2018)

Rapidly growing uterine myoma – should we be afraid of it?
por: Nowak, Marek, et al.
Publicado: (2023)

Dkk1: A key molecule in joint remodelling and fibrosis
por: Klavdianou, Kalliopi, et al.
Publicado: (2017)

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy
por: Lee, Charlotte, et al.
Publicado: (2022)

Editorial: Infection-Related Rheumatic Diseases
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Rheumatic diseases, rheumatism and arthritis
por: Brugsch, Heinrich Georg, 1903-
Publicado: (1957)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Sepsis outcomes in patients with pre-existing liver disease
por: Kopczynska, Maja, et al.
Publicado: (2021)

Survival of cancer patients with pre-existing heart disease
por: O’Neill, Ciaran, et al.
Publicado: (2022)

Should We Be Afraid of Antiplatelet Treatment before Carotid Endarterectomy?
por: Sucu, Nehir, et al.
Publicado: (2018)

Immunotherapy-Associated Hypothyroidism: Comparison of the Pre-Existing With De-Novo Hypothyroidism
por: Kristan, Megan M., et al.
Publicado: (2022)

PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
por: Emery, P
Publicado: (2013)

Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases—A Possible Association with High Rheumatoid Arthritis Disease Activity
por: Hellbacher, Erik, et al.
Publicado: (2022)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Implications of COVID-19 for patients with pre-existing digestive diseases
por: Mao, Ren, et al.
Publicado: (2020)

The influence of pre-existing hypertension on coronavirus disease 2019 patients
por: Wei, Zhi-Yao, et al.
Publicado: (2021)

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
por: Maeda, Osamu
Publicado: (2023)

Q&A: 'Toxic' effects of sugar: should we be afraid of fructose?
por: Tappy, Luc
Publicado: (2012)

Effect of marriage on pre-existing psychoses
por: Behere, Prakash B., et al.
Publicado: (2011)

Together we are stronger: COVID-19 for those of us with pre-existing conditions
por: Pavanello, Stefano
Publicado: (2020)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated?
por: Etehad Tavakol, Mahnaz, et al.
Publicado: (2015)

The Rheumatic Diseases
Publicado: (1950)

The Rheumatic Diseases
Publicado: (1905)

The Rheumatic Diseases
Publicado: (1945)

Fly Me to the Immune: Immunonutrition in Rheumatic Diseases
por: Grammatikopoulou, Maria G., et al.
Publicado: (2023)

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2022)

Sunitinib-Induced Adrenal Crisis in a Patient with Pre-Existing Immunotherapy-Related Hypopituitarism
por: Javaid, Anadil, et al.
Publicado: (2022)

The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?
por: Kohil, Amira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pav4eu38abth7io2cjs6819lf7